Health and Healthcare

Celgene : CELG

All CELG Articles

433 Articles

Chris Lange | Sep 11, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased…

Jon C. Ogg | Sep 9, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Celgene, Ciena, Goldman Sachs, MannKind, Newfield, Tetraphase, Walgreens, Yingli and Many More

Wednesday’s top analyst upgrades, downgrades and initiations include Celgene, Ciena, Goldman Sachs, MannKind, Newfield Exploration, Tetraphase Pharmaceuticals, Walgreens Boots Alliance…

Chris Lange | Aug 26, 2015 at 8:55 AM EDT

Short Sellers Become More Focused in Major Biotechs

The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of…

Chris Lange | Aug 12, 2015 at 8:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech…

Lee Jackson | Aug 8, 2015 at 9:10 AM EDT

Insider Selling at Highest Levels in Months as Earnings Wind Down

All corporations stop insider transactions around the reporting date to avoid the look of any impropriety, and they appear to…

Chris Lange | Jul 27, 2015 at 7:57 AM EDT

Short Sellers Back Off Major Biotechs

ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of…

Chris Lange | Jul 23, 2015 at 9:50 AM EDT

Celgene Earnings Beat and Updated Guidance

Celgene released better-than-expected second-quarter earnings report Thursday before the markets opened.

Paul Ausick | Jul 20, 2015 at 9:35 AM EDT

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been…

Chris Lange | Jul 15, 2015 at 1:05 PM EDT

Is Celgene Transforming Itself With Mergers and Pacts?

Celgene and Receptos announced Tuesday that they had signed a definitive agreement in which the former will acquire the latter…

Chris Lange | Jul 13, 2015 at 7:55 AM EDT

Short Sellers Back Off Big Biotech

24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.

Chris Lange | Jun 30, 2015 at 8:10 AM EDT

What Celgene Now Means for Juno

Celgene and Juno Therapeutics are coming together in a global collaboration for the development and commercialization of immunotherapies.

Chris Lange | Jun 25, 2015 at 7:50 AM EDT

Short Sellers Get More Selective on Big Biotech

The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech…

Chris Lange | Jun 17, 2015 at 10:00 AM EDT

How Much Can Celgene’s Buyback Impact Its Growth?

Celgene announced that its board authorized the repurchase of up to an additional $4.0 billion of its common stock.

Chris Lange | Jun 10, 2015 at 7:55 AM EDT

Short Sellers Lose Some Conviction Against Big Biotech

The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech…

Chris Lange | May 24, 2015 at 9:15 AM EDT

Large Companies With Fastest Revenue and Earnings Growth in 2015

S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.

1 … 15 16 17 18 19 … 29

Celgene : CELG

All CELG Articles

Short Sellers Increase Bets in Major Biotechs

Top Analyst Upgrades and Downgrades: Celgene, Ciena, Goldman Sachs, MannKind, Newfield, Tetraphase, Walgreens, Yingli and Many More

Short Sellers Become More Focused in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Insider Selling at Highest Levels in Months as Earnings Wind Down

Short Sellers Back Off Major Biotechs

Celgene Earnings Beat and Updated Guidance

Top Health Care Earnings for the Week Ahead

Is Celgene Transforming Itself With Mergers and Pacts?

Short Sellers Back Off Big Biotech

What Celgene Now Means for Juno

Short Sellers Get More Selective on Big Biotech

How Much Can Celgene’s Buyback Impact Its Growth?

Short Sellers Lose Some Conviction Against Big Biotech

Large Companies With Fastest Revenue and Earnings Growth in 2015

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Celgene : CELG

All CELG Articles

Short Sellers Increase Bets in Major Biotechs

Top Analyst Upgrades and Downgrades: Celgene, Ciena, Goldman Sachs, MannKind, Newfield, Tetraphase, Walgreens, Yingli and Many More

Short Sellers Become More Focused in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Insider Selling at Highest Levels in Months as Earnings Wind Down

Short Sellers Back Off Major Biotechs

Celgene Earnings Beat and Updated Guidance

Top Health Care Earnings for the Week Ahead

Is Celgene Transforming Itself With Mergers and Pacts?

Short Sellers Back Off Big Biotech

What Celgene Now Means for Juno

Short Sellers Get More Selective on Big Biotech

How Much Can Celgene’s Buyback Impact Its Growth?

Short Sellers Lose Some Conviction Against Big Biotech

Large Companies With Fastest Revenue and Earnings Growth in 2015

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip